How to treat allergic cough and asthma

Many people only know that they cough when they have a cold, but they don’t know much about allergic coughs. In fact, allergic coughs are also called allergic bronchitis, or cough variant asthma. Generally, it has two characteristics, that is, there will be a period of chronic cough, coughing without cause, lasting more than two months, and it is usually a dry cough, or with a small amount of sputum, and it will get worse when inhaling some irritating odors. So how should this condition be treated?

Sublingual desensitization therapy

Sublingual desensitization, sublingual desensitization therapy is to use the extract of allergens to drip under the tongue to make the respiratory mucosa tolerate, thereby alleviating or controlling allergic symptoms and achieving the purpose of desensitization treatment. Its clinical characteristics are:

The world's fastest-growing desensitization therapy (i.e. specific immunotherapy or immunotherapy) method is in line with the rational symptomatic and causal treatment plan recommended by the World Health Organization.

Treating both the symptoms and the root cause: Fundamental treatment of allergic diseases, with significant effects and thorough desensitization; overcoming the limitations of traditional hormone chemical drugs that only treat symptoms when the disease occurs and only treat the symptoms but not the root cause, and as the duration of use increases, there are varying degrees of adverse reactions that may lead to a certain degree of drug resistance.

High safety: Globally, no serious side effects have occurred in 30 years of use, which maximizes the long-term safety of desensitization therapy; it avoids serious systemic adverse reactions (including anaphylactic shock and even death) that may be caused by injectable desensitization therapy, thereby reducing the psychological burden on medical staff and patients.

For patients with allergic asthma caused by dust mites, 3 to 9 months of sublingual dust mite immunotherapy can reduce the frequency and duration of asthma attacks, reduce the inhaled dose of glucocorticoids, reduce airway responsiveness and improve lung function indicators. There are also changes in in vivo immunological indicators before and after treatment, including increased serum IgG4 levels and improved Th2/Th1 cell ratios. Since the drug is administered sublingually, serious adverse reactions such as anaphylactic shock usually do not occur. A very small number of patients may occasionally experience mild rash or mild diarrhea, which can be recovered by stopping treatment or reducing the dosage. The mechanism of sublingual desensitization therapy is that there are a large number of Langerhans cells in the sublingual mucosa, which absorb trace amounts of dust mite allergens and process them into mite polypeptide information, which are then presented to Th0 cells, causing the Th0 cells to transform into Th1 cells, thereby preventing the occurrence of allergic reactions.

The above is about the treatment of allergic cough. Generally speaking, the treatment that many parents are more concerned about is, because many people currently have a common understanding of the treatment of allergic cough, that is, the essence of allergic cough and asthma is the same, so there are many similarities in its treatment methods. Generally, you will go to the hospital for desensitization injections, and gradually increase the dosage and concentration to improve it.